These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6182783)

  • 1. [Increase of the GvH reaction after alloimmunization. Influence of the serologically defined determinants of the H-2 system].
    Brock J; Siegl E; Schulze HA
    Allerg Immunol (Leipz); 1982; 28(2):91-6. PubMed ID: 6182783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specificity of cell-mediated cytotoxicity. II. Cytotoxic lymphocytes after in vitro allogeneic sensitization in the H-2 system].
    Schulze HA; Brock J
    Allerg Immunol (Leipz); 1983; 29(2):100-7. PubMed ID: 6224410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of GVH reaction in F1 hybrid mice by foetal liver cells.
    Siegl E; Brock J; Schulze HA
    Folia Biol (Praha); 1982; 28(6):409-14. PubMed ID: 6761153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of polyinosinic:polycytidylic acid on the graft-versus-host reaction. III: Increased severity of the reaction with delayed pI:C treatment.
    Peres A; Amlani S; Kornbluth M; Seemayer TA; Lapp WS
    Transplantation; 1989 Jul; 48(1):80-4. PubMed ID: 2749889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific depletion of graft-versus-host activity of normal or allosensitized parental spleen cells.
    Rózalska B
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):417-21. PubMed ID: 6200087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigen-specific inhibition of donor cell activity in the graft vs. host reaction].
    Divanian Kh
    Eksp Med Morfol; 1986; 25(4):47-9. PubMed ID: 2434302
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specificity of cell mediated cytotoxicity. I. Cytotoxic reactions in H-2 system after allogeneic sensitization in vivo].
    Schulze HA; Brock J; Siegl E
    Allerg Immunol (Leipz); 1982; 28(2):109-17. PubMed ID: 6182781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of major histocompatibility complex genes in the reaction of macrophages and thymocytes during induction of T-effectors of the graft vs host reaction. III. Effect of antisera against H-2 complex antigens on the realization of the process].
    Lutsan NI; Anfalova TV; Galaktionov VG; Golenishchev VIu
    Genetika; 1987 Mar; 23(3):449-55. PubMed ID: 3569893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of graft versus host reactivity in pregnant mice.
    Nicklin S; Billington WD
    Clin Exp Immunol; 1982 Jul; 49(1):135-41. PubMed ID: 7127896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
    Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
    J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual recognition of parental and F lymphocytes. III. Parental determinants recognized by F host mice in resistance to graft-vs-host-associated immunosuppression map to H-2Db.
    Shearer GM; Polisson RP
    J Immunol; 1981 Feb; 126(2):545-7. PubMed ID: 6161180
    [No Abstract]   [Full Text] [Related]  

  • 16. Depressed lymphoproliferative response in mixed leukocyte reaction after Mis-locus alloimmunization.
    Solana R; Alonso MC; de la Fuente M; Paniagua JA; Rojas R; Peña J
    Rev Esp Fisiol; 1984 Mar; 40(1):1-4. PubMed ID: 6235554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of H-2-subregion differences for graft-versus-host autoimmunity in mice: superiority of the differences at class-II H-2 antigens (I-A/I-E).
    Kimura M; van Rappard-van der Veen FM; Gleichmann E
    Clin Exp Immunol; 1986 Sep; 65(3):542-52. PubMed ID: 3490938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary in vivo T cell reactivity of NZB grafts in H-2 identical allogenic hosts.
    Botzenhardt U; Siegmund J; Siegmund V; Müller J
    Immunobiology; 1983 Jul; 165(1):36-45. PubMed ID: 6604015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific depletion of GVH reactivity of mouse lymphocytes by adsorption on allogeneic fibroblast monolayers.
    Lonai P; Eliraz A; Wekerle H; Feldman M
    Transplant Proc; 1973 Mar; 5(1):857-9. PubMed ID: 4144465
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses.
    Hurtenbach U; Shearer GM
    J Immunol; 1983 Apr; 130(4):1561-6. PubMed ID: 6220057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.